<unk> (nasal) is a hemostatic and metabolic agent that is FDA approved for the treatment of central cranial diabetes insipidus, temporary polyuria and polydipsia following head trauma or surgery in the pituitary region.   Common adverse reactions include transient headache, nausea, nasal congestion, rhinitis, flushing, abdominal cramps, nosebleed, sore throat, cough, and upper respiratory infections.
Desmopressin 
Prothrombin complex concentrate
Recombinant factor VIIa
Platelet rich plasma
Fresh frozen plasma
Factor XIII concentrate
Drotrecogin alfa
Sebelipase alfa